Bionano Genomics, Inc. (BNGO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-232,493
-232,493
-132,596
-72,435
-41,106
Depreciation & amortisation
13,912
13,912
9,840
3,370
1,479
Deferred income taxes
0
0
1,760
-5,777
0
Stock-based compensation
15,178
15,178
22,417
9,719
1,554
Change in working capital
-14,769
-14,769
-27,939
-7,652
-3,440
Accounts receivable
-2,296
-2,296
-2,251
-493
2,087
Inventory
-4,150
-4,150
-23,676
-15,928
-4,201
Accounts payable
-1,995
-1,995
1,949
6,781
-1,810
Other working capital
-126,872
-126,872
-128,118
-73,387
-38,314
Other non-cash items
-2,981
-2,981
794
1,481
1,264
Net cash provided by operating activities
-125,181
-125,181
-124,816
-71,927
-38,314
Cash flows from investing activities
Investments in property, plant and equipment
-1,691
-1,691
-3,302
-1,460
-
Acquisitions, net
0
0
-31,344
-49,086
-2,450
Purchases of investments
-111,264
-111,264
-84,195
-313,392
0
Sales/maturities of investments
137,017
137,017
200,888
86,483
0
Other investing activities
-
-
694
-607
-
Net cash used for investing activities
24,158
24,158
82,767
-278,062
-2,450
Cash flows from financing activities
Debt repayment
-9,047
-9,047
-36
-15,005
-7,258
Common stock issued
57,697
57,697
23,128
342,711
39,934
Other financing activities
-14,965
-14,965
-578
-1,704
-2,000
Net cash used provided by (used for) financing activities
113,815
113,815
23,007
336,111
61,902
Net change in cash
12,857
12,857
-19,080
-13,878
21,138
Cash at beginning of period
5,491
5,491
24,571
38,449
17,311
Cash at end of period
18,348
18,348
5,491
24,571
38,449
Free cash flow
Operating cash flow
-125,181
-125,181
-124,816
-71,927
-38,314
Capital expenditure
-1,691
-1,691
-3,302
-1,460
-
Free cash flow
-126,872
-126,872
-128,118
-73,387
-38,314
© 2024 Yahoo. All rights reserved.